<DOC>
	<DOCNO>NCT01148173</DOCNO>
	<brief_summary>Central nervous system ( CNS ) relapse aggressive lymphoma rare devastate complication . There therapy standard , conventional approach palliative . This study investigate intensive chemotherapy CNS penetrating drug follow high-dose chemotherapy autologous stem cell transplantation potentially curative approach .</brief_summary>
	<brief_title>High-dose Chemotherapy Stem Cell Transplantation Central Nervous System ( CNS ) Relapse Aggressive Lymphomas</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Aggression</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<criteria>highlymalignant nonHodgkinsLymphoma , mantlecell lymphoma follicular lymphoma 3° CNS relapse ( meningeal or/and intraparenchymal ) without systemic lymphoma manifestation ECOG performance score ≤2 active infection negative HIVserology adequate renal function ( creatinine clearance &gt; 50 ml/min ) adequate bone marrow function ( granulocytes &gt; 1500/μl , platelet &gt; 80000/μl ) normal bilirubin , AST &lt; 3 x UNL negative pregnancy test newly diagnose NHL primary CNS involvement indolent NHL , lymphoblastic NHL Burkitt lymphoma precede CNS irradiation pretreatment CNS relapse corticosteroid immunosuppression , concomitant immunosuppressive therapy , status organ transplantation allogenous stem cell transplantation second cancer basalioma cervical carcinoma situ within last 5 year unfit receive intensive chemotherapy pregnancy breastfeed know intolerance MTX , ifosfamide , Depocyte , cytarabine , thiotepa , carmustine etoposide</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>CNS relapse</keyword>
	<keyword>aggressive lymphoma</keyword>
	<keyword>HD-ASCT</keyword>
</DOC>